Clinical Trials Sponsored by Grupo Procrearte

Total 614 results

Overture Life
Clinica Juana Crespo; Grupo Procrearte

Recruiting

Metabolomics Non Selection Study - Vitrolife Media

Infertility

Spain, Argentina
Procreatec
Sociedad Espanola Fertilidad

Unknown

Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation. (EmbryoSEL)

Embryo Implantation

Spain
Grupo Lusófona

Completed

Exploring the Impact of Individualized Pleasure-Oriented Exercise Sessions in a Health Club Setting

Affect

Portugal
Grupo Lusófona

Unknown

Effect of High-intensity Intermittent Games on Cardiorespiratory Fitness and Body Composition in Children (HIIG)

Children, Physical Activity

Chile
Procreatec
Hospital Universitario 12 de Octubre

Completed

Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF

EMBRYO IMPLANTATION

Spain
Grupo Hospital de Madrid

Completed

Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients (TT)

Progression Free Survival

Spain
Grupo de Cirurgia Vascular

Unknown

Treatment of Leg Telangiectasias With Nd:YAG 1064nm

Telangiectasias

Brazil
Grupo Hospital de Madrid

Unknown

Angiogenic Switch in Patients With Colorectal Cancer (ANGIOSWITCH)

Colorectal Cancer

Spain
Grupo Hospital de Madrid

Completed

Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma Patients (TT)

Rectal Cancer

Spain
Grupo de Cirurgia Vascular

Completed

Use of Oxybutynin to Treat Axillary Hyperhidrosis

Axillary Hyperhidrosis | Osmidrosis

Brazil
Clínica Medellín - Grupo Quirónsalud

Completed

Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine

Covid-19

Colombia
Grupo Hospital de Madrid

Unknown

Endoscopic Sleeve Gastroplasty for Treatment of Obesity

Obesity

Spain
Grupo Hospital de Madrid

Completed

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer

Pancreatic Cancer

Spain
Grupo Espanol de Tumores Neuroendocrinos

Recruiting

Nutrition in Gastroenteropancreatic Neuroendocrine Tumor (NUTRIGETNE)

Gastroenteropancreatic Neuroendocrine Tumor

Spain
Grupo Espanol de Tumores Neuroendocrinos

Recruiting

GETNE Registration of Thyroid Cancer

Thyroid Cancer

Spain
Grupo Espanol de Tumores Neuroendocrinos

Active, not recruiting

Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.

Neuroendocrine Tumors | Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine Tumor

Spain
Grupo Cooperativo de Hemopatías Malignas

Withdrawn

Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Multiple Myeloma

Mexico
Grupo Oncológico Gallego
Pivotal S.L.

Unknown

Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer

Breast Cancer

Spain
Grupo Español Multidisciplinar de Melanoma

Recruiting

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain (GEM-1801)

Advanced Cancer | Melanoma Stage Iv | Melanoma Stage Iii

Spain
Grupo Español de Rehabilitación Multimodal

Active, not recruiting

POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol

Colorectal Surgery | Enhanced Recovery After Surgery | Critical Pathways | Chemotherapy, Adjuvant | Retrospective Studies

Spain
Grupo Espanol de Tumores Neuroendocrinos

Completed

Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin (DUNE)

Neuroendocrine Tumors | Neuroendocrine Neoplasm of Lung

Spain
Grupo Cooperativo de Hemopatías Malignas

Completed

Treatment of SARS Caused by COVID-19 With Ruxolitinib

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Grupo Espanol de Tumores Neuroendocrinos

Completed

Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria (CRIPNET)

Pancreatic Neuroendocrine Tumors

Spain
Grupo Español de Rehabilitación Multimodal

Unknown

Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer (POWER4)

Postoperative Complications | Gastric Cancer | Perioperative Care

Spain
Grupo Español de Rehabilitación Multimodal

Unknown

Validity of Aortic Pulse Wave Velocity in Predicting the 6- Minute Walking Test Before Major Non-cardiac Surgery (6WAVE)

Surgery | Perioperative/Postoperative Complications | Exercise Tolerance

Spain
Grupo Español de Rehabilitación Multimodal

Unknown

Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2) (POWER2)

Arthroplasty, Replacement, Knee | Arthroplasty, Replacement, Hip

Spain
Grupo Español de Síndromes Mielodisplásicos

Completed

Spanish Registry of Erythropoietic Stimulating Agents Study (SPRESAS)

Myelodysplastic Syndrome
Grupo Espanol de Tumores Neuroendocrinos

Completed

A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) (PALBONET)

Pancreatic Neuroendocrine Cancer

Spain
Grupo Espanol de Tumores Neuroendocrinos

Completed

Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET (EVERLAR)

Gastrointestinal Neoplasms

Spain
Grupo Cooperativo de Hemopatías Malignas

Recruiting

Myeloid Mutations Register in R/R CML

Chronic Myeloid Leukaemia Recurrent | Chronic Myeloid Leukemia, in Relapse

Mexico
Grupo Cooperativo de Hemopatías Malignas

Withdrawn

Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Mexico
Grupo Rescue S.A.S República Dominicana

Completed

SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study

Covid19

Dominican Republic
Grupo Cooperativo de Hemopatías Malignas

Completed

Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)

Mexico
Grupo Espanol de Tumores Neuroendocrinos

Completed

Pazopanib as Single Agent in Advanced NETs

Advanced/Metastatic Neuroendocrine Tumors

Spain
Grupo Español de Rehabilitación Multimodal

Completed

Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER)

Postoperative Complications | Colorectal Surgery | Perioperative Care | Critical Pathways

Spain
Ciprés Grupo Médico CGM SC

Completed

PC-300 Tea Effect on Triglyceride Levels

Hypertriglyceridemia
Grupo Español Multidisciplinar de Melanoma

Completed

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma (BRAFV600)

Stage IV Skin Melanoma

Spain
Grupo Gallego de Investigaciones Oncologicas

Completed

Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients (XELTA)

Metastatic Adenocarcinoma of the Pancreas

Spain
Grupo Espanol de Investigacion en Sarcomas

Recruiting

Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas (SYNERGIAS)

Soft Tissue Sarcoma | Bone Tumors | Small Round-cell Sarcomas

Spain
Grupo Espanol de Investigacion en Sarcomas

Recruiting

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)

Soft Tissue Sarcoma | Bone Sarcoma

Spain, United Kingdom, Italy
Grupo Espanol de Investigacion en Sarcomas

Completed

ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities

Osteosarcoma

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo

Completed

Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients (AVEVAC)

Colorectal Carcinoma

Spain
Grupo Español Multidisciplinar de Melanoma
GlaxoSmithKline

Completed

Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain (DEIS)

Malignant Melanoma Stage IV | Malignant Melanoma Stage IIIc

Spain
Grupo Espanol de Investigacion en Sarcomas

Terminated

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

Sarcoma

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo

Unknown

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. (BECOX)

Metastatic Colorectal Cancer

Spain
Grupo Español de Investigación en Neurooncología

Completed

Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

Glioblastoma

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo

Completed

Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment

Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)

Spain
Grupo Español de Investigación en Neurooncología

Unknown

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Glioblastoma
Grupo Espanol de Investigacion en Sarcomas

Unknown

Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma

Soft Tissue Sarcoma

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo

Recruiting

GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer. (REVEAL)

Patients With Locally Advanced Rectal Cancer

Spain

Clinical Trials Sponsored by Grupo Procrearte

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations